首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Hepatitis E Virus (HEV) Strains in Serum Samples Can Replicate Efficiently in Cultured Cells Despite the Coexistence of HEV Antibodies: Characterization of HEV Virions in Blood Circulation
【2h】

Hepatitis E Virus (HEV) Strains in Serum Samples Can Replicate Efficiently in Cultured Cells Despite the Coexistence of HEV Antibodies: Characterization of HEV Virions in Blood Circulation

机译:尽管存在HEV抗体但血清样品中的戊型肝炎病毒(HEV)菌株可以在培养细胞中高效复制:血液循环中HEV病毒颗粒的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently developed a cell culture system for hepatitis E virus (HEV) in PLC/PRF/5 and A549 cells, using fecal specimens from HEV-infected patients. Since transfusion-associated hepatitis E has been reported, we examined PLC/PRF/5 and A549 cells for the ability to support replication of HEV in various serum samples obtained from 23 patients with genotype 1, 3, or 4 HEV. HEV progenies emerged in culture media of PLC/PRF/5 cells, regardless of the coexistence of HEV antibodies in serum but dependent on the load of HEV inoculated (31% at 2.0 × 104 copies per well and 100% at ≥3.5 × 104 copies per well), and were successfully passaged in A549 cells. HEV particles in serum, with or without HEV antibodies, banded at a sucrose density of 1.15 to 1.16 g/ml, which was markedly lower than that for HEV particles in feces, at 1.27 to 1.28 g/ml, and were nonneutralizable by immune sera in this cell culture system. An immuno-capture PCR assay of HEV virions treated with or without detergent indicated that HEV particles in serum are associated with lipids and HEV ORF3 protein, similar to those in culture supernatant. By immunoprecipitation, it was found that >90% of HEV particles in the circulation exist as free virions not complexed with immunoglobulins, despite the coexistence of HEV antibodies. These results suggest that our in vitro cell culture system can be used for propagation of a wide variety of HEV strains in sera from various infected patients, allowing extended studies on viral replication specific to different HEV strains.
机译:我们最近使用HEV感染患者的粪便标本开发了PLC / PRF / 5和A549细胞中的戊型肝炎病毒(HEV)细胞培养系统。由于已经报道了与输血相关的戊型肝炎,我们检查了PLC / PRF / 5和A549细胞在从23个基因型1、3或4型HEV患者中获得的各种血清样本中支持HEV复制的能力。 HEV后代出现在PLC / PRF / 5细胞的培养基中,与血清中HEV抗体的共存无关,但取决于接种的HEV的载量(每孔2.0×10 4 拷贝时31%)每孔≥3.5×10 4 拷贝100%),并成功地在A549细胞中传代。含或不含HEV抗体的血清中的HEV颗粒的蔗糖密度为1.15至1.16 g / ml,显着低于粪便中HEV颗粒的蔗糖密度,为1.27至1.28 g / ml,并且不能被免疫血清中和在这个细胞培养系统中。使用或不使用去污剂处理过的HEV病毒粒子的免疫捕获PCR分析表明,血清中的HEV颗粒与脂质和HEV ORF3蛋白相关,与培养上清液中的相似。通过免疫沉淀发现,尽管HEV抗体共存,但循环中> 90%的HEV颗粒以不与免疫球蛋白复合的游离病毒体的形式存在。这些结果表明,我们的体外细胞培养系统可用于从各种感染患者的血清中传播多种HEV株,从而允许对不同HEV株特异的病毒复制进行扩展研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号